Drugs.com - FDA MedWatch Alerts

Public Safety Notification on Amniotic Fluid Eyedrops

Audience: Patients, Health Care Practitioners October 17, 2024 Update: In August 2024, FDA received information from two consumers who reported adverse events such as shooting pain in the eyes after using Regener-Eyes, an ophthalmic drug product...

Feb 9, 2025 - 21:44
 0
Public Safety Notification on Amniotic Fluid Eyedrops
Audience: Patients, Health Care Practitioners October 17, 2024 Update: In August 2024, FDA received information from two consumers who reported adverse events such as shooting pain in the eyes after using Regener-Eyes, an ophthalmic drug product...
Read More

Tags:

Previous Article

Endo Expands Voluntary Recall of Clonazepam Orally Disintegrating Tablets, USP (...

Next Article

C&A Naturistics Issues Voluntary Nationwide Recall of AK Forte Tablets con Ortig...

Related Posts

FDA Warns Consumers to Not Purchase or Use Unapproved Inhalant Products Marketed for Alertness and Energy Boosting

FDA Warns Consumers to Not Purchase or Use Unapproved I...

Feb 9, 2025  0

Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil

Boulla LLC Issues Voluntary Nationwide Recall of Boom M...

Feb 9, 2025  0

Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination

Bionpharma Inc. Issues Voluntary Nationwide Recall of A...

Feb 9, 2025  0